These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 25679167)

  • 1. Depth dose perturbation by a hydrogel fiducial marker in a proton beam.
    Zhang M; Reyhan M; Kim LH
    J Appl Clin Med Phys; 2015 Jan; 16(1):5090. PubMed ID: 25679167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculated stopping-power ratios, water/air, for clinical proton dosimetry (50-250 MeV).
    Medin J; Andreo P
    Phys Med Biol; 1997 Jan; 42(1):89-105. PubMed ID: 9015811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric impact of gold markers implanted closely to lung tumors: a Monte Carlo simulation.
    Shiinoki T; Sawada A; Ishihara Y; Miyabe Y; Matsuo Y; Mizowaki T; Kokubo M; Hiraoka M
    J Appl Clin Med Phys; 2014 May; 15(3):4594. PubMed ID: 24892332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the dose perturbation around gold and steel fiducial markers in a medical linac through Geant4 Monte Carlo simulation.
    Pontoriero A; Amato E; Iatí G; De Renzis C; Pergolizzi S
    J Xray Sci Technol; 2015; 23(2):135-40. PubMed ID: 25882726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental depth dose curves of a 67.5 MeV proton beam for benchmarking and validation of Monte Carlo simulation.
    Faddegon BA; Shin J; Castenada CM; Ramos-Méndez J; Daftari IK
    Med Phys; 2015 Jul; 42(7):4199-210. PubMed ID: 26133619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical investigation for developing injectable fiducial markers using a mixture of BaSO4 and biodegradable polymer for proton therapy.
    Ahn SH; Gil MS; Lee DS; Han Y; Park HC; Sohn JW; Kim HY; Shin EH; Yu JI; Noh JM; Cho JS; Ahn SH; Choi DH
    Med Phys; 2015 May; 42(5):2626-37. PubMed ID: 25979054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton stopping powers averaged over beam energy spectra.
    Laitano RF; Rosetti M
    Phys Med Biol; 2000 Oct; 45(10):3025-43. PubMed ID: 11049186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pencil beam algorithm for magnetic resonance image-guided proton therapy.
    Padilla-Cabal F; Georg D; Fuchs H
    Med Phys; 2018 May; 45(5):2195-2204. PubMed ID: 29532490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oblique incidence for broad monoenergetic proton beams.
    Jette D; Yuan J; Chen W
    Med Phys; 2010 Nov; 37(11):5683-90. PubMed ID: 21158280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A particle track-repeating algorithm for proton beam dose calculation.
    Li JS; Shahine B; Fourkal E; Ma CM
    Phys Med Biol; 2005 Mar; 50(5):1001-10. PubMed ID: 15798272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monte Carlo simulations of the dosimetric impact of radiopaque fiducial markers for proton radiotherapy of the prostate.
    Newhauser W; Fontenot J; Koch N; Dong L; Lee A; Zheng Y; Waters L; Mohan R
    Phys Med Biol; 2007 Jun; 52(11):2937-52. PubMed ID: 17505081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying the effect of air gap, depth, and range shifter thickness on TPS dosimetric accuracy in superficial PBS proton therapy.
    Shirey RJ; Wu HT
    J Appl Clin Med Phys; 2018 Jan; 19(1):164-173. PubMed ID: 29239528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing the modulation transfer function (MTF) of proton/carbon radiography using Monte Carlo simulations.
    Seco J; Oumano M; Depauw N; Dias MF; Teixeira RP; Spadea MF
    Med Phys; 2013 Sep; 40(9):091717. PubMed ID: 24007150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technical Note: Experimental verification of magnetic field-induced beam deflection and Bragg peak displacement for MR-integrated proton therapy.
    Schellhammer SM; Gantz S; Lühr A; Oborn BM; Bussmann M; Hoffmann AL
    Med Phys; 2018 Jul; 45(7):3429-3434. PubMed ID: 29763970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effect of dose distortion by fiducial markers in spot-scanning proton therapy with a limited number of fields: a simulation study.
    Matsuura T; Maeda K; Sutherland K; Takayanagi T; Shimizu S; Takao S; Miyamoto N; Nihongi H; Toramatsu C; Nagamine Y; Fujimoto R; Suzuki R; Ishikawa M; Umegaki K; Shirato H
    Med Phys; 2012 Sep; 39(9):5584-91. PubMed ID: 22957624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the dosimetric impact of a Ni-Ti fiducial marker in carbon ion and proton beams.
    Herrmann R; Carl J; Jäkel O; Bassler N; Petersen JB
    Acta Oncol; 2010 Oct; 49(7):1160-4. PubMed ID: 20831508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid fiducial marker applicability in proton therapy of locally advanced lung cancer.
    Scherman Rydhög J; Perrin R; Jølck RI; Gagnon-Moisan F; Larsen KR; Clementsen P; Riisgaard de Blanck S; Fredberg Persson G; Weber DC; Lomax T; Andresen TL; Munck Af Rosenschold P
    Radiother Oncol; 2017 Mar; 122(3):393-399. PubMed ID: 28104299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose perturbations and image artifacts caused by carbon-coated ceramic and stainless steel fiducials used in proton therapy for prostate cancer.
    Cheung J; Kudchadker RJ; Zhu XR; Lee AK; Newhauser WD
    Phys Med Biol; 2010 Dec; 55(23):7135-47. PubMed ID: 21076190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
    De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
    Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual ring multilayer ionization chamber and theory-based correction technique for scanning proton therapy.
    Takayanagi T; Nihongi H; Nishiuchi H; Tadokoro M; Ito Y; Nakashima C; Fujitaka S; Umezawa M; Matsuda K; Sakae T; Terunuma T
    Med Phys; 2016 Jul; 43(7):4150. PubMed ID: 27370135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.